Pyrroles
Medchemexpress LLC Atorvastatin sodium | 134523-01-6 | MFCD08458204 | 99.9% | 580.62 | C33H34FN2NaO5 | 10 MG
Atorvastatin sodium is the sodium salt form of atorvastatin, an HMG-CoA reductase inhibitor used in research to study cholesterol biosynthesis, lipid metabolism, and related cellular effects. It is supplied as a high-purity white to off-white solid and is characterized by standard analytical data including HPLC and molecular weight determinations.
- High purity (HPLC) for reproducible assay results.
- Molecular formula C33H34FN2NaO5 and molecular weight 580.62.
- White to off-white solid appearance suitable for handling and storage.
- Suitable for biochemical and cellular studies of HMG-CoA reductase activity.
- Batch-specific certificate of analysis available for quality verification.
Aobchem (3-Bromo-5-chloro-4-iodophenyl)(methyl)sulfane | 95% | CAS 2709327-50-2 | C7H5BrClIS | 250mg
(3-Bromo-5-chloro-4-iodophenyl)(methyl)sulfane | 95% | CAS 2709327-50-2 | C7H5BrClIS | 250mg
Medchemexpress LLC TLR7 agonist 3 | 1229024-78-5 | 99.9% | 312.41 g/mol | C18H24N4O | 100 MG
TLR7 agonist 3 is a small-molecule agonist of Toll-like receptor 7 used as a research reagent to stimulate innate immune responses and evaluate anticancer immunomodulatory strategies. It is supplied as a high-purity solid suitable for in vitro and in vivo studies.
- Potent agonist of Toll-like receptor 7 (TLR7) for immune activation studies.
- Applicable for conjugation to targeting ligands to direct activity to specific cell types.
- High purity solid suitable for analytical and biological assays.
- Soluble in DMSO (100 mg/mL) and ethanol (≥50 mg/mL); compatible with common in vivo formulations at ≥2.5 mg/mL.
- Offered in multiple pack sizes including 100 mg for dosing flexibility.
![Medchemexpress LLC [2-chloro-3-(trifluoromethyl)phenyl]-[(4R)-1-(5-fluoropyrimidin-2-yl)-4-methyl-6,7-dihydro-4H-triazolo... | 1627902-21-9 | MFCD31556312 | 99.3% | 440.78 g/mol | C18H13ClF4N6O | 10 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000227025.png-250.jpg)
Medchemexpress LLC [2-chloro-3-(trifluoromethyl)phenyl]-[(4R)-1-(5-fluoropyrimidin-2-yl)-4-methyl-6,7-dihydro-4H-triazolo... | 1627902-21-9 | MFCD31556312 | 99.3% | 440.78 g/mol | C18H13ClF4N6O | 10 MG
JNJ-54175446 is a brain-penetrant, selective purine P2X7 receptor antagonist used in central nervous system research and clinical investigations of neuroinflammation and mood disorders. It is characterized by high potency at human and rat P2X7 receptors and is available in both solid and solution formats across multiple package sizes.
- Brain-penetrant P2X7 receptor antagonist.
- High potency: pIC50 8.46 (human), 8.81 (rat).
- Available as solid and DMSO solution; multiple package sizes from 1 mg to 500 mg.
- High reported purity of 99.3%.
- Suitable for in vitro and in vivo CNS pharmacology studies.
![Medchemexpress LLC Ethyl 2-amino-4-methyl-5-[(3-nitrophenyl)formamido]thiophene-3-carboxylate | 303141-21-1 | 99.7% | 50 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000233735.png-250.jpg)
Medchemexpress LLC Ethyl 2-amino-4-methyl-5-[(3-nitrophenyl)formamido]thiophene-3-carboxylate | 303141-21-1 | 99.7% | 50 MG
DC-S239 is a selective small-molecule inhibitor of the histone methyltransferase SET7 (SETD7) used for research applications. It is reported to inhibit SET7 with an IC50 of 4.59 μM and is supplied as a solid for laboratory use.
- Selective SET7 inhibitor with reported IC50 of 4.59 μM.
- High purity (99.7%).
- Molecular weight 349.36 g/mol; formula C15H15N3O5S.
- Solid, yellow-orange physical form suitable for handling and storage.
- Available as a 50 mg research vial.